These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 129008)

  • 1. The metabolic clearance rate of dehydroisoandrosterone sulfate. IV. Acute effects of induced hypertension, hypotension, and naturesis in normal and hypertensive pregnancies.
    Gant NF; Madden JD; Siiteri PK; MacDonald PC
    Am J Obstet Gynecol; 1976 Jan; 124(2):143-8. PubMed ID: 129008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic clearance rate of dehydroisoandrosterone sulfate. V. Studies of essential hypertension complicating pregnancy.
    Gant NF; Madden JD; Chand S; Worley RJ; Strong JD; MacDonald PC
    Obstet Gynecol; 1976 Mar; 47(3):319-26. PubMed ID: 129716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic clearance rate of dehydroisoandrosterone sulfate. VI. Studies of eclampsia.
    Gant NF; Madden JD; Chand S; Worley RJ; Siiteri PK; MacDonald PC
    Obstet Gynecol; 1976 Mar; 47(3):327-30. PubMed ID: 129717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic clearance rate of dehydroisoandrosterone sulfate. VII. Effect of lateral versus supine recumbency.
    Singley T; Madden JD; Chand S; Worley RJ; MacDonald PC; Gant NF
    Obstet Gynecol; 1976 Apr; 47(4):419-22. PubMed ID: 130573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus.
    Cotton DB; Gonik B; Dorman KF
    Surg Gynecol Obstet; 1985 Sep; 161(3):240-4. PubMed ID: 4035539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy.
    Lammintausta R
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):581-4. PubMed ID: 365799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension.
    Suonio S; Saarikoski S; Tahvanainen K; Pääkkönen A; Olkkonen H
    Am J Obstet Gynecol; 1986 Jul; 155(1):122-5. PubMed ID: 3728580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic clearance rate of dehydroisoandrosterone sulfate. III. The effect of thiazide diuretics in normal and future pre-eclamptic pregnancies.
    Gant NF; Madden JD; Siteri PK; MacDonald PC
    Am J Obstet Gynecol; 1975 Sep; 123(2):159-63. PubMed ID: 126019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol.
    Rosenfeld J; Bott-Kanner G; Boner G; Nissenkorn A; Friedman S; Ovadia J; Merlob P; Reisner S; Paran E; Zmora E
    Eur J Obstet Gynecol Reprod Biol; 1986 Aug; 22(4):197-204. PubMed ID: 3743860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure response in hypertensive pregnancies treated with cortisol.
    Iams JD; Semchyshyn S; O'Shaughnessy R; Moynihan V; Zuspan FP
    Clin Exp Hypertens (1978); 1980; 2(5):923-32. PubMed ID: 7428568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypertensive emergencies of pregnancy.
    Nissen JC
    Clin Pharm; 1982; 1(4):334-43. PubMed ID: 6764393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report.
    Bott-Kanner G; Schweitzer A; Schoenfeld A; Joel-Cohen J; Rosenfeld JB
    Isr J Med Sci; 1978 Apr; 14(4):466-8. PubMed ID: 669924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
    Kuzniar J; Skret A; Piela A; Szmigiel Z; Zaczek T
    Obstet Gynecol; 1985 Oct; 66(4):453-8. PubMed ID: 4047535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of hypertension in pregnancy.
    Gant NF; Worley RJ
    Clin Obstet Gynaecol; 1977 Dec; 4(3):613-33. PubMed ID: 145921
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of nitroprusside and hydralazine in hypertensive pregnant ewes.
    Ring G; Krames E; Shnider SM; Wallis KL; Levinson G
    Obstet Gynecol; 1977 Nov; 50(5):598-602. PubMed ID: 909667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension.
    Griffis KR; Martin JN; Palmer SM; Martin RW; Morrison JC
    Am J Perinatol; 1989 Oct; 6(4):437-41. PubMed ID: 2789542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern and rates of metabolism of maternal plasma dehydroisoandrosterone sulfate in human pregnancy.
    Madden JD; Siiteri PK; MacDonald PC; Gant NF
    Am J Obstet Gynecol; 1976 Aug; 125(7):915-20. PubMed ID: 133611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats.
    Soltis EE
    J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal considerations. Metabolic clearance rate of maternal plasma dehydroisoandrosterone sulfate.
    Worley RJ; Everett RB; Madden JD; MacDonald PC; Gant NF
    Semin Perinatol; 1978 Jan; 2(1):15-28. PubMed ID: 153584
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.